Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Dec 2012 for Merrimack Pharmaceuticals INC, €25k.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
John Mendelsohn: trading record in brief
One trade, one date: on 18 December 2012, John Mendelsohn disclosed an open-market purchase of €25k in Merrimack Pharmaceuticals Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John Mendelsohn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 5,000 shares@ US$6.63Common StockSEC:0001179110-12-017850:0Canonical exit: 14 Mar 2013 (T+90)
1 of 1 declaration
